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Abstract
Background: Adjustable shunts are very popular in the management of hydrocephalus and are
believed to help in minimizing the number of surgical revisions. The drawback with almost all
constructions is that they may be accidentally readjusted in relatively weak magnetic fields (around
30–40 mTesla)
Materials and methods: The ProGav Miethke shunt is composed of an adjustable ballon-spring
valve unit and an integrated over-drainage compensating gravitational device (known as the shunt
assistant). A mechanical 'brake' is intended to prevent changes to the valve's performance level in
a strong magnetic field. We evaluated the performance and hydrodynamic properties of a sample
of three valves in the UK Shunt Evaluation Laboratory.
Results: All the shunts showed good mechanical durability over the three-month period of testing,
and good stability of hydrodynamic performance over a one-month period
The pressure-flow performance curves, operating, opening and closing pressures fell within the
limits specified by the manufacturer, and changed according to the programmed performance
levels. The operating pressure increased when the shunt assistant was in the vertical position, as
specified. The valve has a low hydrodynamic resistance (0.53 mm mmHg ml-1 min-1). External
programming proved to be easy and reliable. Strong magnetic fields from a 3 Tesla MR scanner
were not able to change the programming of the valve.
Conclusion: The ProGAV shunt is an adjustable, low resistance valve that is able to limit posture-
related over-drainage. Unlike other adjustable valves, the ProGAV cannot be accidentally re-
adjusted by external magnetic field such as a 3T MR scanner.
Background
A hydrocephalus shunt drains excess cerebrospinal fluid
(CSF) to elsewhere in the body. Ideally, the shunt should
restore a normal CSF circulation. Therefore, the rate of
drainage should be proportional to the positive difference
between the CSF pressure and the sagittal sinus pressure.
With a negative pressure difference, the drainage should
cease. Full restoration of this mechanism is unrealistic
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because most shunts drain fluid into the peritoneal or
atrial cavities not into the sagittal sinus. Hence, the driving
pressure is a pressure difference between inlet (ventricles)
and outlet (peritoneal or atrial) compartments. The other
requirements of an ideal shunt are:
• The resistance of an open shunt taken together with the
natural CSF outflow resistance (usually increased in
hydrocephalus) should be close to the normal resistance
to CSF outflow, i.e. 6 to 10 mmHg ml-1 min-1 [1]
￿ Flow should remain constant under constant pressure
conditions.
￿ Flow through the shunt should not depend on the body
posture or be affected by body temperature, external
(environmental) pressure (within the physiological range
for subcutaneous pressure) or the pulsatile component of
CSF pressure.
￿ Opening and closing pressures (the pressure at which
flow starts and ceases) should remain constant under the
conditions listed above.
￿ Reversal of flow through the shunt should be impossi-
ble.
When programmable shunts became available they for
the first time allowed fine-tuning of their operating pres-
sure  in vivo. This enabled any mismatch between the
shunt's operating pressure and the requirements for 'opti-
mal' ICP, i.e. the pressure that gives the best and quickest
relief from symptoms, to be adjusted without the need for
surgery to replace the shunt. However, it was found that
following MRI scanning, a diagnostic procedure fre-
quently used on patients with hydrocephalus, almost all
programmable shunts had their settings changed by the
powerful magnets used by the scanning equipment [2].
Further studies have been published, indicating that prac-
tically all models of programmable valves can be acciden-
tally readjusted by magnetic fields as low as a fraction of
10-2 Tesla [3-5]. This increases the risk of accidental re-
adjustment of the valve by household items such as mag-
netic toys [4], holders and furniture latches.
The newly released Miethke proGAV® shunt is a program-
mable valve with an integrated siphon compensating
gravitational device [6]. It incorporates a brake system to
prevent the shunt being reset by an external magnetic field
of up to 3 Tesla [7].
The aim of this study was to assess the hydrodynamic
properties of the shunt and the efficacy of its design fea-
tures in order to provide accurate and independent infor-
mation for the neurosurgeon selecting a shunt.
Materials and methods
Shunt
The ProGAV shunt (Miethke GMBH & Co KG, Potsdam,
Germany) is composed of two units: an adjustable unit
and a non-adjustable gravitational shunt assistant. Both
the units have titanium shells.
The adjustable unit uses a ball-in-cone valve system. The
tension of the spring holding the ball in place can be
adjusted by turning the rotor (torsion bar) using the exter-
nal magnetic adjustment tool, thus changing the operat-
ing pressure. The valve has a brake system that holds the
rotor in place to prevent unwanted re-adjustment when
the shunt is exposed to an external magnetic field. To
release the brake, a downward force (800 to 1600 gram-
force) is applied to the unit using the adjustment tool
(Figure 1). The valve has a diameter of 18 mm. It has a rel-
atively large internal volume compared to other models,
which is intended to minimize the risk of obstruction.
The gravitational unit (shunt assistant) increases the
opening pressure of the shunt when the patient is vertical
by blocking the inlet flow using a gravity-assisted ball
bearing. If the patient is horizontal, the ball no longer
blocks the opening and the unit provides substantially
less resistance. When in the vertical position, the opening
pressure of the ProGAV is the sum of the opening pressure
of the adjustable unit and the gravitational unit. The grav-
itational unit is available with a graded cross-sectional
area of aperture supporting the ball, which is intended to
compensate for the 'siphoning' that occurs in CSF-filled
tubing of different lengths. The setting of the shunt assist-
ant, expressed in cm should be equivalent to the distance
between the right atrium of the heart and the outlet of the
peritoneal catheter.
The valve can be implanted on the chest rather than on the
skull. Although the position of the valve is not important,
the shunt assistant should be always parallel to the longi-
tudinal body axis.
A special compass and an adjustment tool are supplied:
The compass reads the valve's current setting and can also
be used to pinpoint the shunt's location if it cannot be
found by simple palpation. The adjustment instrument is
used to change the setting of the shunt, allowing transcu-
taneous adjustment. To adjust the shunt, force must be
applied onto its superior surface with the tool to unlock
the braking mechanism. The adjustment tool's built in
magnet then moves the internal mechanism of the shunt
to set it at the desired resistance.
Testing rig and protocol
The detailed description of testing rig and methodology
has been published previously [7]. Three Miethke proGAVCerebrospinal Fluid Research 2006, 3:9 http://www.cerebrospinalfluidresearch.com/content/3/1/9
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Diagrams of the Miethke proGAV® shunt adapted from http://www.miethke.com with the permission of authors Figure 1
Diagrams of the Miethke proGAV® shunt adapted from http://www.miethke.com with the permission of authors. A: Adjustable 
unit in 'closed' state. The ball-in-cone valve is closed and drainage is blocked. B: Adjustable unit in 'open' state. Differential pres-
sure overcomes the spring force. The ball moves out of the cone and the gap opens, allowing drainage. C: Gravitational unit in 
vertical position. When patient is upright unit closes, increasing effective opening pressure of the valve. Drainage occurs when 
the differential pressure exceeds the combined opening pressures of both unit. D: Gravitational unit in horizontal position. The 
unit is open and the opening pressure of the valve is determined only by the adjustable unit. E: Internal adjustment mechanism 
of the shunt with details of profiled rotor controlling pre-load of the spring supporting ball F: The magnetic tool is used to turn 
the rotor. In neutral position rotor cannot move even in a presence of very strong magnetic field (up to 3T) as the brake is 
engaged. G: The turning is only possible when the central part of valve's casing is depressed, releasing the brake.Cerebrospinal Fluid Research 2006, 3:9 http://www.cerebrospinalfluidresearch.com/content/3/1/9
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shunts were mounted in three identical testing rigs. The
shunts were submerged in a water bath at a constant tem-
perature of 37°C and at a depth of approximately 1 cm.
De-ionised and de-aerated water, from either the syringe
infusion pump or the fluid container, was used to perfuse
the shunt. A pulse pressure generator was used to simulate
the pulsation of ICP seen in-vivo. The input pressure to the
shunt was measured using a luer lock pressure transducer
that was placed at the same level as the shunt. Fluid flow-
ing through the shunt was collected in a container placed
on an electronic balance.
Measurement was controlled by a standard IBM compati-
ble personal computer with software designed in-house.
The flow rate through the shunt was calculated by the pro-
gram, which read and zeroed the balance periodically.
Weighing the fluid outflow in increments enabled the
influence of fluid vaporisation from the outlet container
to be cancelled. In this way the relationship between dif-
ferential pressure and flow was evaluated using a pressure-
flow performance curve. Opening and closing pressure,
and hydrodynamic resistance of the opened shunt, were
calculated.
Repeated tests were carried out over a three months period
and included an assessment of how flow-pressure per-
formance changed. Tests performed included: measure-
ment over 28 consecutive days, at different settings, in
different temperatures, in horizontal and vertical posi-
tions, with the presence of variable pulse amplitude, with
and without distal drain, before and after a simulated scan
in a 3 Tesla MRI magnet.
Linear regression was used to analyse the relation between
measured closing pressure and valve pressure setting. Data
are shown as mean values, with 95% confidence bars
where appropriate. The significance for differences
between different valves was tested using a t-test.
The study was conducted in the U.K. Shunt Evaluation
Laboratory in Cambridge. Measurement protocol was a
standard protocol used for assessment of hydrocephalus
shunts [8]. The results were obtained and interpreted
independently on the manufacturer.
Results
The typical pressure-flow curves for a valve, working at
three different performance levels are presented in Figure
2. The valve, without a distal catheter and a pulsatile pres-
sure wave, had almost linear characteristics.
The static resistance of the shunt was 0.53 mmHg ml-1
min-1 (95% confidence limit: +/- 0.04 mmHg ml-1 min-1).
The connection of a standard 76 cm distal catheter
increased the resistance of the valve to around 3.0 mmHg
ml-1 min-1.
Regression between measurement of the operating pres-
sure and setting of the valves showed a significant linear
relationship (R = 0.97) with a 95% limit for predictors +/
- 3.5 mm Hg (Figure 3). The programming tool was very
straightforward and easy to use. Reliability of program-
ming was high, the valve was correctly adjusted in >95%
cases. Verification of programming is quick and easy and
it does not require an X-ray scan.
All three shunts were scanned in a 3 Tesla MRI machine.
We ran a routine T1/T2 weighted sequence and the timing
of the MRI scanning was comparable to human scans
(about 20 min). The result of the scan is shown in Figure
4, where the outlines of the shunts are visible as well as the
large artefacts they produced. The shunts were then
assessed to see if the setting or hydrodynamic properties
had altered following the scan and no differences were
found. Programming of the shunt was not affected by the
high magnetic field exposure. If the artefacts are likely to
pose a potential problem for brain scans, this could be
avoided by placing the shunt over the chest.
When the shunt assistant was in the vertical position, the
pressure-flow performance curve and operating pressure
were shifted upwards. The amount of shift was equivalent
to the change in the opening pressure of the shunt assist-
ant due to its orientation, in this case 30 cmH2O. Within
Shapes of pressure-flow curves for the three shunts tested at  three different pressure settings: 4 cm H2O, 10 cm H2O and  16 cm H2O (left to right) Figure 2
Shapes of pressure-flow curves for the three shunts tested at 
three different pressure settings: 4 cm H2O, 10 cm H2O and 
16 cm H2O (left to right). The pressure units used for these 
measurements were mm Hg. However the manufacturer 
used cm H20 for the settings on the shunts.Cerebrospinal Fluid Research 2006, 3:9 http://www.cerebrospinalfluidresearch.com/content/3/1/9
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the tested range of 34° – 40°C, temperature had no signif-
icant effect on shunt performance. Pulse amplitude super-
imposed on inlet pressure had a tendency to decrease
operating pressure by 3.5 mm Hg per 10 mm Hg of peak-
to-peak amplitude.
No significant differences in measured parameters were
found between the three valves tested. There was no sig-
nificant difference detected in parameters over the 28-day
test period. Preassembled junctions did not break when a
test specimen was subjected to a load of 1 kg force for 1
min. All junctions remained free from leakage when the
water pressure was increased to 3 kPa (about 25 mm Hg).
The valve did not show any reflux when tested according
to the International Standards Organisation (ISO) stand-
ard. Valves did not exhibit reversal of flow for an outlet-
inlet differential pressure of up to 200 mm Hg.
Discussion
Historically, unlike drugs, surgical devices have been
introduced onto the market with a minimum of inde-
pendent scrutiny, occasionally resulting in unfortunate
incidents such as the problems associated with early mod-
els of silicone breast implants. There are also examples of
shunts being withdrawn from the market when perform-
ance differed markedly from the manufacturer's specifica-
tions. However, more recently, ISO standards and
randomized controlled trials have been established to
assess the efficacy of surgical devices and help provide sur-
geons and their patients with safer products.
ISO 7197 (see http://www.nssn.org) describes a set of
standards that ensures a minimum assessment of a valve's
performance and examines the consistency of the manu-
facturing process that is thought to be adequate. Perhaps
surprisingly, not all shunt manufacturers adhere to these
standards [8]. As such, due to the varying and inconsistent
data supplied by manufacturers concerning their product,
it was considered important that formal studies, such as
the one described here, were carried out by independent
organisations. It was in this light that the UK shunt labo-
ratory was created in 1993 [8].
Due to the limitations of this in vitro study it was not pos-
sible to assess whether the shunt conformed to all the ISO
standards, but the results from the tests performed have
been promising and meet the criteria required, in that the
shunt performed to the manufacturer's specification. The
programming of the shunt functioned as expected.
Increasing the shunt's setting led to a similar increase in
the observed operating pressure, as specified by the man-
ufacturer. This trend was significant for all settings.
Good results were obtained with respect to testing the two
key features of the ProGAV. The brake system performed
satisfactorily, reducing the chance of accidental repro-
gramming of the shunt. The shunt was not affected by the
magnets and is deemed to be MRI safe (in vitro) with
respect to program resetting. However no system is infal-
lible, and as the opening pressure setting can be very crit-
ical in some hydrocephalic patients it would perhaps be
prudent for the shunt's setting to be checked after a scan.
MRI scan of three shunts Figure 4
MRI scan of three shunts. The shunts were placed on testing 
block of glycerin (20 × 20 × 20 cm) and a 3T MRI scan was 
performed. Black areas show artifacts on MRI image.
Linear regression plot between measurement points and set- tings of the valve (R = 0.97) Figure 3
Linear regression plot between measurement points and set-
tings of the valve (R = 0.97). The 95% confidence limits for 
predictors are represented by the outer dashed line and the 
means for each shunt by the inner dashed line.Cerebrospinal Fluid Research 2006, 3:9 http://www.cerebrospinalfluidresearch.com/content/3/1/9
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The integrated anti-siphon device also performed well. A
substantial increase in operating pressure was observed
when the gravitational unit was orientated in a vertical
position. Hopefully this should minimise the effect of any
tendency to posture-related over-drainage.
The decrease in operating pressure seen when a pulse pres-
sure was superimposed on a static differential pressure
was noted, but this is common to all pressure-differential
valves. [9]. Hence, flow through the valve may be affected
by the pulsatile component of CSF pressure due to the car-
diac pulse and breathing. As such it is important to
remember that this is a laboratory study and that the
hydrodynamic properties of the shunt may be different in
vivo.
A very low hydrodynamic resistance was measured: 0.53
mmHg ml-1 min-1, much lower than the physiological
value of 6 – 10 mmHg ml-1 min [1]. Even with a standard
peritoneal catheter (usually approximately 90 cm long
and with an internal diameter of 1.2 mm) that has a resist-
ance of 2.5–3.5 mmHg ml-1  min-1 this would only
increase the resistance to about 60% of the physiological
value. As the catheter represents about 85% of overall
resistance of the complete setup, care must be taken when
shortening it.
This low resistance in the open state means that the valve
can cope with a sudden build up of pressure and it might
therefore be considered for use in the 20–30% of hydro-
cephalic patients experiencing intermittent intracranial
hypertension [8]. Logically, for patients suffering from
this type of hydrocephalus the choice of shunt is restricted
to those with a low resistance. On the other hand, shunts
with low resistance are often associated with an increased
risk of over-drainage. If the over-drainage is posture
related then the anti-siphoning device should reduce this
problem. However if it is due to nocturnal vasogenic activ-
ity when the patient is horizontal then this will still
remain an issue [9].
In the longer lasting pressure-flow tests, which last several
hours, the shunt produced consistent patterns of flow that
did not vary over the trial period. Hence the proGAV is
expected to be a reliable shunt when used in patients.
One important question that remains is how well does the
shunt's performance in the laboratory translate to its abil-
ity to restore CSF flow in the patient, given that the labo-
ratory conditions mimic only in part conditions within
the human body? This is a very complex question. There
is very limited literature available on this subject and what
there is appears to be contradictory. Performance is heav-
ily dependent on a patient's individual CSF dynamics and
therefore shunt implantation should ideally be done in
conjunction with an analysis of each patient's dynamics
[10].
A mechanism for post-marketing surveillance, such as the
UK Shunt Registry [11], should be established to closely
monitor the proGAV performance in-vivo.
Conclusion
Testing of the Miethke proGAV revealed it to be a reliable
model that performed well in vitro. The brake system per-
formed well and should minimise accidental resetting due
to MRI scanning. The anti-siphon also works well and
should help reduce posture-related over-drainage.
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